157 related articles for article (PubMed ID: 12753316)
1. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
[TBL] [Abstract][Full Text] [Related]
2. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
[TBL] [Abstract][Full Text] [Related]
3. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases.
Sumida Y; Nakashima T; Yoh T; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Nakamura H; Yodoi J
Liver; 2001 Oct; 21(5):295-9. PubMed ID: 11589765
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Nakashima T; Sumida Y; Yoh T; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Kashima K; Nakamura H; Yodoi J
Antioxid Redox Signal; 2000; 2(4):687-94. PubMed ID: 11213474
[TBL] [Abstract][Full Text] [Related]
5. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
7. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
8. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients.
Tutal E; Sezer S; Ibis A; Bilgic A; Ozdemir N; Aldemir D; Haberal M
Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489
[TBL] [Abstract][Full Text] [Related]
9. The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.
Nascimento MM; Suliman ME; Bruchfeld A; Hayashi SY; Manfro RC; Qureshi AR; Pecoits-Filho R; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
Nephrol Dial Transplant; 2004 Dec; 19(12):3112-6. PubMed ID: 15466879
[TBL] [Abstract][Full Text] [Related]
10. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.
Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Vinson S; Mousa M; Gitnick G
Am J Kidney Dis; 2000 Jan; 35(1):122-9. PubMed ID: 10620553
[TBL] [Abstract][Full Text] [Related]
11. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection.
Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Shigematsu M; Kashiwagi S
Am J Gastroenterol; 2000 Feb; 95(2):490-6. PubMed ID: 10685756
[TBL] [Abstract][Full Text] [Related]
12. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
[TBL] [Abstract][Full Text] [Related]
13. Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients.
Peng YS; Chiang CK; Hsu SP; Pai MF; Hung KY; Kao JH
Blood Purif; 2005; 23(2):106-12. PubMed ID: 15640602
[TBL] [Abstract][Full Text] [Related]
14. Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection.
Altintepe L; Kurtoglu E; Tonbul Z; Yeksan M; Yildiz A; Türk S
Clin Nephrol; 2004 May; 61(5):347-51. PubMed ID: 15182130
[TBL] [Abstract][Full Text] [Related]
15. Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.
Sumida Y; Kanemasa K; Yamaoka Y; Imamura S; Katoh N; Nakashima T; Tachibana S; Mitsuyoshi H; Itoh Y; Okanoue T
Liver Int; 2006 Sep; 26(7):827-33. PubMed ID: 16911465
[TBL] [Abstract][Full Text] [Related]
16. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C.
de Almeida JP; Liberatti LS; Barros FE; Kallaur AP; Lozovoy MA; Scavuzzi BM; Panis C; Reiche EM; Dichi I; Simão AN
Nutrition; 2016 Mar; 32(3):362-7. PubMed ID: 26847403
[TBL] [Abstract][Full Text] [Related]
17. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Signal-to-Cutoff Ratio of Hepatitis C Virus Antibody Assay in Predicting HCV Viremia among Hemodialysis Patients.
Kao HH; Chen KS; Lin CL; Chang JJ; Lee CH
Nephron; 2015; 130(2):127-33. PubMed ID: 26065912
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
[TBL] [Abstract][Full Text] [Related]
20. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
